1. Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial. Issue 12 (December 2022) Authors: Lazarus, Rajeka; Querton, Benedicte; Corbic Ramljak, Irena; Dewasthaly, Shailesh; Jaramillo, Juan Carlos; Dubischar, Katrin; Krammer, Michael; Weisova, Petronela; Hochreiter, Romana; Eder-Lingelbach, Susanne; Taucher, Christian; Finn, Adam; Bethune, Claire; Boffito, Marta; Bula, Marcin; Burns, Fi... Journal: Lancet infectious diseases Issue: Volume 22:Issue 12(2022) Page Start: 1716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗